The Ledger
Every statement that passed quotation and attribution checks. Mix any filter with any other: certainty 1/5, debate potential 5/5, or both at once.
why aren't all 6 resolved? a statement only gets an assessment when the public record can support or contradict it. opinions and what-ifs never can, and 0 checkable ones are still open, waiting for their date. predictions held up or didn't; assertions are supported or contradicted. on every card: ▮▮▮▮▮ certainty · ▮▮▮▮▮ debate potential. speakers are clickable
Sadeghi: 23andMe's genetic testing is ineffective for disease risk assessment
“Toilet meat technology missing millions and millions of genetic markers. Effectively, it's not actually useful for any really disease risk assessment.”
Sadeghi: 23andMe is not HIPAA compliant
“One of the most shocking things about 23 means is it's actually not HIPAA compliant, right? It doesn't follow the gold standard clinical regulations that ensure your data is safeguarded.”
Sadeghi: 23andMe cannot develop drugs using microarray genetic data
“They really viewed data gathering as a means to make drugs, but because it's such a small sliver of your DNA, you actually can't really make drugs off of it”
Sadeghi: Nucleus Genomics is exploring an acquisition of 23andMe assets
“I think one thing this nucleus actively is looking into right now, considering whether it makes sense, you know, earlier, I'm sure you remember, you know, we explored the possibility of acquiring and we're looking into right now whether that would make sense t…”
Sadeghi: Nucleus Genomics Is Years Ahead in Replacing 23andMe
“You go from Blockbuster to Netflix, you go from, you know, Blackberry to the iPhone, you go from MySpace to Facebook, and now you're going from 23 and Me to Nucleus Genomics, right? The industry is wide open, Nucleus is years ahead, and we're going to seize th…”